CYTOKINETICS INC 8-K

What Happened

• On May 5, 2026, Cytokinetics, Inc. (CYTK) filed a Form 8-K (Item 2.02) to announce its results of operations and financial condition for the quarter ended March 31, 2026.
• The company furnished the full text of the press release reporting those results as Exhibit 99.1 to the 8-K. The report was signed by John O. Faurescu, SVP, Deputy General Counsel & Secretary.

Key Details

• Filing date: May 5, 2026; reporting period: quarter ended March 31, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition (press release furnished).
• Exhibit: 99.1 — Press release dated May 5, 2026.
• Administrative note: the cover page was formatted in Inline XBRL; report signed by company secretary John O. Faurescu.

Why It Matters

• This 8-K is the company’s official release of its quarterly results; investors should read the furnished press release and related SEC filings for the detailed numbers (revenue, net income/loss, cash position and any guidance or operational updates).
• Because the filing simply furnishes the press release under Item 2.02, it does not itself amend prior financial statements—rather it communicates the company’s reported quarterly performance and any disclosures included in the press release.